Cite
HARVARD Citation
Manini, M. et al. (n.d.). Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal. Digestive and liver disease. 49 (1), pp. e10-e11. [Online].